The Dementia Consortium has expanded to include Johnson & Johnson Innovation, Takeda and Evotec, who join the unique £9.5 million charity-industry dementia drug discovery collaboration.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.